High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2) - next deadline
Deadline: November 01, 2018
Amount: The total annual cost for individual awards is expected to vary, depending on the scope of the project and the number of participating institutions. Application budgets are not limited but need to reflect the actual needs of the proposed project. Maximum project period is 5 years.
This program supports high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The interdisciplinary approach should generate a community research resource for the broader community, which may include discovery-based or hypothesis-generating science. This program will support research projects that accelerate critical breakthroughs, early and applied research on cutting-edge technologies, and new approaches to improve the synergy and interactions among multi- and interdisciplinary research teams, including sharing of data and other resources to further advance research in this area. This FOA seeks novel approaches in areas that address specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that will advance the area in significant ways designed to accelerate scientific progress in the understanding, treatment and prevention of diseases within the mission of NIDDK.
- Clinical trial optional
- The mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is to conduct and support medical research and research training and to disseminate science-based information on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases
- The scope of this FOA includes, but is not limited to, the following:
- Groundbreaking, innovative, high impact and cross-cutting research projects that will improve and accelerate biomedical research.
- Basic, clinical and translational projects that could fundamentally enhance the research enterprise and that require the participation, interaction, coordination and integration of activities carried out in multiple research laboratories.
- Creation of large scale unique resources, accelerated application of high throughput, and other novel technologies.
- Deployment of critical infrastructure, resources, tools, and methodologies that substantially accelerate collaborative, multi and interdisciplinary basic, translational, and/or clinical research.
- Implementation of large scale research projects that are carried out using new and creative collaborative agreements and partnerships.
- Discovery-based and hypothesis-generating science.
- Creative approaches to overcome barriers to basic, translational, or clinical research using novel tools, technologies, and services.
- RC2 projects are not intended to support:
- Traditional investigator-initiated and highly focused studies (best supported by the R01 or P01 mechanisms).
- Research that is a logical extension of ongoing work.
- Core (or related) services to supplement the budgets of existing R01-type efforts.
- Groups of investigators at the same institution who would normally interact and collaborate in the absence of a collaborative grant.